Gene Therapy Production

Plasmid DNA serves as the genetic template for viral vector production, making plasmid quality foundational to downstream viral titer and product consistency. Fermentation-based plasmid production at scale requires bacterial strains, growth media, and lysis conditions optimized for high plasmid yield while minimizing genomic DNA contamination. Fermentation platforms support plasmid manufacturing from development through commercial manufacturing. Peptones can enhance cell density and plasmid productivity during fermentation. Analytical tools that quantify residual host cell DNA verify plasmid purity and offer process control across fermentation, lysis, and purification.

Establish high-density cell culture conditions to support consistent viral vector yields and process robustness. Cell expansion strategies influence transfection efficiency, viral productivity, and impurity burden. Suspension-adapted HEK293 cells grown in chemically defined, serum-free media reduce lot-to-lot variability, mitigate adventitious agent risk associated with serum-containing systems, and simplify downstream processing. Scalable bioreactors create controlled environments for high-density suspension culture, maintaining dissolved oxygen, pH, and nutrient levels critical for reproducible vector production. Bioprocess controllers enable real-time monitoring and automated adjustments, improving consistency and enabling scale-up decisions.

Optimize transfection conditions to achieve efficient plasmid delivery and maximize functional viral vector yield. Transfection efficiency and timing directly impact vector titer, capsid assembly, and the ratio of full to empty particles. Lipid-based reagents facilitate plasmid–lipid complex formation and cell uptake, enabling transient transfection workflows that scale from development to manufacturing. Bioprocess containers and fluid transfer solutions integrate plasmid mixing, cell culture handling, and harvest operations into closed systems, reducing contamination risk. These platforms maintain aseptic processing while enabling flexible configurations adapted to different vector systems and production scales.

Maintain process control across development to achieve consistent viral vector quality and productivity. Vector production workflows align cell culture formats, transfection methods, and harvest strategies to balance titer, purity, and facility utilization. Adherent systems offer established protocols and moderate capital investment, while suspension culture systems enable higher volumetric productivity and simplified scale-up. Cell factory automation equipment can help reduce manual handling in adherent workflows, automating media exchange, harvest, and cleaning steps. Process control solutions that monitor temperature, pH, and dissolved oxygen throughout production help maintain quality attributes and support process validation and control strategies.

Reduce process-related impurities and enrich functional viral vectors through scalable downstream purification workflows. Chromatography-based separations address host cell proteins, residual DNA, and empty capsids, which reduce product purity and potency. Affinity chromatography resins enable single-step capture of multiple adeno-associated virus (AAV) serotypes, simplifying process development and improving yield compared to multi-step processes. Scalable purification platforms maintain resolution and binding capacity across scales. AAV purification solutions for gene therapy integrate capture, polishing, and concentration steps. Process Liquid and Buffer Prep Services offer formulated buffers that reduce in-house preparation time and variability.

Implement analytical testing workflows to verify product quality and regulatory compliance throughout gene therapy manufacturing. Lot release testing requires methods that detect adventitious agents, quantify residual impurities, and measure vector potency. qPCR-based assays enable rapid quantitation of viral genomes, offering titer data quickly to support process decisions and release testing. qPCR-based testing solutions detect host cell DNA and process-related nucleic acids with sensitivity meeting regulatory requirements for residual DNA limits. Microbial detection tools offer rapid mycoplasma screening, reducing testing timelines compared to culture-based methods. Validated documentation supports regulatory requirements without delaying release.

Protect product integrity during final processing through controlled handling, storage, and filling operations. Fill–finish solutions designed for viral vectors address shear sensitivity, surface adsorption, and cold chain requirements. Single-use containers, such as the Thermo Scientific Labtainer Bioprocess Container, maintain sterile conditions from bulk drug substance through formulation. Closed transfer systems minimize exposure to environmental contamination during filling operations while maintaining process efficiency. Temperature-controlled environments protect vector stability during storage and transport. Sample preparation and automation solutions reduce manual handling, improving data quality.